Diy13/iStock via Getty Images
Traws Pharma Shares (NASDAQ: WORK) soared 24% in post-market trading on Friday thanks to encouraging results from a Phase 1 study of the company’s drug, Tivoxavir Marboxil, in the treatment of H5N1 bird flu.
The study showed a single dose of